Abstract
We present the case of a 43-year-old-man with a past medical history of HIV with recently initiated HAART and existing PML that presented with altered mental status. The initial diagnosis was deemed to be PML-IRIS; however, neuroimaging brought into question this diagnosis. Flow cytometry performed from the cerebrospinal fluid revealed diffuse large B cell lymphoma. JC virus may act in an oncogenic role similarly to EBV and predispose to CNS lymphomas. Patients with PML caused by JC virus may develop secondary malignancies.
Similar content being viewed by others
References
Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono MI, Fibbia GC, Mena M, Finazzi MG, Guaraldi G, Ammassari A, d’Arminio Monforte A, Cinque P, e Luca A, Italian Registry Investigative Neuro AIDS (IRINA) Study Group (2003) Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 9(1):47–53
Barzon L, Trevisan M, Marino F, Guzzardo V, Palù G (2009) Primary bilateral adrenal B-cell lymphoma associated with EBV and JCV infection. Infect Agents Cancer 4(1):1
Cesarman E (2002) Epstein-Barr virus (EBV) and lymphomagenesis. Front Biosci 7:e58–e65
Chapagain ML, Nerurkar VR (2010) Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J Infect Dis 202(2):184–191
Del Valle L, Enam S, Lara C, Miklossy J, Khalili K, Gordon J (2004) Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol 78(7):3462–3469
Dojcinov SD, Fend F, Quintanilla-Martinez L (2018) EBV-positive lymphoproliferations of B- T- and NK-cell derivation in non-immunocompromised hosts. Pathogens (Basel, Switzerland) 7(1):28. https://doi.org/10.3390/pathogens7010028
Gallia GL, Del Valle L, Laine C, Curtis M, Khalili K (2001) Concomitant progressive multifocal leucoencephalopathy and primary central nervous system lymphoma expressing JC virus oncogenic protein, large T antigen. Mol Pathol 54(5):354
Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D, Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort (2009) Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 10(12):1152
Hernández-Losa J, Fedele CG, Pozo F, Tenorio A, Fernández V, Castellví J et al (2005) Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer 103(2):293–298
Krynska B, Del Valle L, Croul S, Gordon J, Katsetos CD, Carbone M, Giordano A, Khalili K (1999) Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas. Proc Natl Acad Sci 96(20):11519–11524
Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5(1):49–73
Manabe YC, Campbell JD, Sydnor E, Moore RD (2007) Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 46(4):456
Mantina H, Wiggill TM, Carmona S, Perner Y, Stevens WS (2010) Characterization of lymphomas in a high prevalence HIV setting. J Acquir Immune Defic Syndr 53(5):656
Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, Häusler D, Häusler D (2012) Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol 123(2):235–245
Ratnam I, Chiu C, Kandala NB, Easterbrook PJ (2006) Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 42(3):418
Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, Moreno A, Quereda C, Moreno S, Corral I (2016) Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy. Eur J Neurol 23(5):919–925
Shah R, Bag AK, Chapman PR, Cure JK (2010) Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65(6):431–439
Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9(4):425–437
Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 72(17):1458–1464
Wei G, Liu CK, Atwood WJ (2000) JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes. J Neurovirol 6(2):127–136
Acknowledgments
We would like to acknowledge all the nurses, providers, support staff, and students for their assistance in the care of this patient. We would also like to thank Dr. Gunjan Parikh at the University of Maryland School of Medicine, for his guidance and support in creating this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Reddi, A., Patel, N. & Morris, N.A. Diffuse large B cell lymphoma secondary to JC virus in progressive multifocal leukoencephalopathy. J. Neurovirol. 25, 883–886 (2019). https://doi.org/10.1007/s13365-019-00760-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-019-00760-z